VA

Vaxxas

3 known investors

vaxxas.com ↗

Biotechnology company enhancing vaccine performance with its HD-MAP high-density microarray skin-delivery platform, targeting infectious disease and oncology.

Investors · 3

R&

R&D Tax Incentive

TO

Torrey Pines InvestmentSan Diego

ON

OneVenturesreportedSydney · $3.3M – $13.2M